APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Newcastle Disease Vaccine

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Selected research

Market Analysis & Forecast

Global Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032

Report ID 174016770225 December 2025191 pages

Choose your research edition.

Industry ResearchNewcastle Disease Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.

Read the full market overview

This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.

Newcastle Disease Vaccine Segment by Company

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

DHN

Zoetis

ChengDu Tecbond

Elanco (Lohmann)

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Segment by Application

Chicken

Duck & Goose

Other

Newcastle Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Newcastle Disease Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newcastle Disease Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccines Major Manufacturers Table 3. Killed Vaccines Major Manufacturers Table 4. Global Newcastle Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Chicken Major Manufacturers Table 6. Duck & Goose Major Manufacturers Table 7. Other Major Manufacturers Table 8. Newcastle Disease Vaccine Industry Trends Table 9. Newcastle Disease Vaccine Industry Drivers Table 10. Newcastle Disease Vaccine Industry Opportunities and Challenges Table 11. Newcastle Disease Vaccine Industry Restraints Table 12. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Newcastle Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Newcastle Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Newcastle Disease Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Newcastle Disease Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 18. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses) Table 19. Global Newcastle Disease Vaccine Sales by Region (2027-2032) & (M Doses) Table 20. Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Newcastle Disease Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Newcastle Disease Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Newcastle Disease Vaccine Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 27. Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application Table 30. Global Newcastle Disease Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Newcastle Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Newcastle Disease Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Newcastle Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 40. Global Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 41. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Newcastle Disease Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Newcastle Disease Vaccine Price by Type (2021-2026) & (USD/K Doses) Table 44. Global Newcastle Disease Vaccine Price by Type (2027-2032) & (USD/K Doses) Table 45. Global Newcastle Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Newcastle Disease Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Newcastle Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 51. Global Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 52. Global Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 53. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Newcastle Disease Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Newcastle Disease Vaccine Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Newcastle Disease Vaccine Price by Application (2027-2032) & (USD/K Doses) Table 57. Merial Company Information Table 58. Merial Business Overview Table 59. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 60. Merial Newcastle Disease Vaccine Product Portfolio Table 61. Merial Recent Development Table 62. CEVA Company Information Table 63. CEVA Business Overview Table 64. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 65. CEVA Newcastle Disease Vaccine Product Portfolio Table 66. CEVA Recent Development Table 67. QYH Biotech Company Information Table 68. QYH Biotech Business Overview Table 69. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 70. QYH Biotech Newcastle Disease Vaccine Product Portfolio Table 71. QYH Biotech Recent Development Table 72. Ringpu Biology Company Information Table 73. Ringpu Biology Business Overview Table 74. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 75. Ringpu Biology Newcastle Disease Vaccine Product Portfolio Table 76. Ringpu Biology Recent Development Table 77. Yebio Company Information Table 78. Yebio Business Overview Table 79. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 80. Yebio Newcastle Disease Vaccine Product Portfolio Table 81. Yebio Recent Development Table 82. Harbin Veterinary Research Institute Company Information Table 83. Harbin Veterinary Research Institute Business Overview Table 84. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 85. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio Table 86. Harbin Veterinary Research Institute Recent Development Table 87. Merck Animal Health Company Information Table 88. Merck Animal Health Business Overview Table 89. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 90. Merck Animal Health Newcastle Disease Vaccine Product Portfolio Table 91. Merck Animal Health Recent Development Table 92. DHN Company Information Table 93. DHN Business Overview Table 94. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 95. DHN Newcastle Disease Vaccine Product Portfolio Table 96. DHN Recent Development Table 97. Zoetis Company Information Table 98. Zoetis Business Overview Table 99. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 100. Zoetis Newcastle Disease Vaccine Product Portfolio Table 101. Zoetis Recent Development Table 102. ChengDu Tecbond Company Information Table 103. ChengDu Tecbond Business Overview Table 104. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 105. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio Table 106. ChengDu Tecbond Recent Development Table 107. Elanco (Lohmann) Company Information Table 108. Elanco (Lohmann) Business Overview Table 109. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 110. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio Table 111. Elanco (Lohmann) Recent Development Table 112. FATRO Company Information Table 113. FATRO Business Overview Table 114. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 115. FATRO Newcastle Disease Vaccine Product Portfolio Table 116. FATRO Recent Development Table 117. CAVAC Company Information Table 118. CAVAC Business Overview Table 119. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 120. CAVAC Newcastle Disease Vaccine Product Portfolio Table 121. CAVAC Recent Development Table 122. Vaksindo Company Information Table 123. Vaksindo Business Overview Table 124. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 125. Vaksindo Newcastle Disease Vaccine Product Portfolio Table 126. Vaksindo Recent Development Table 127. North America Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 130. North America Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 131. North America Newcastle Disease Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 132. North America Newcastle Disease Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 133. North America Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 136. North America Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 137. North America Newcastle Disease Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 138. North America Newcastle Disease Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 139. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. North America Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 143. North America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 144. North America Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 145. North America Newcastle Disease Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 146. North America Newcastle Disease Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 147. United States Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Canada Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Mexico Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Europe Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 153. Europe Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 154. Europe Newcastle Disease Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 155. Europe Newcastle Disease Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 156. Europe Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 159. Europe Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 160. Europe Newcastle Disease Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 161. Europe Newcastle Disease Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 162. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Europe Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 166. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 167. Europe Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 168. Europe Newcastle Disease Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 169. Europe Newcastle Disease Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 170. Germany Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 171. France Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 172. U.K. Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 173. Italy Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 174. Russia Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 175. Spain Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 176. Netherlands Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Switzerland Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Sweden Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Poland Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 180. China Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 181. China Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 182. China Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 183. China Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 184. China Newcastle Disease Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 185. China Newcastle Disease Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 186. China Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 187. China Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 188. China Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 189. China Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 190. China Newcastle Disease Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 191. China Newcastle Disease Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 192. Asia Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 195. Asia Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 196. Asia Newcastle Disease Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 197. Asia Newcastle Disease Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 198. Asia Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 201. Asia Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 202. Asia Newcastle Disease Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 203. Asia Newcastle Disease Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 204. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 208. Asia Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 209. Asia Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 210. Asia Newcastle Disease Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 211. Asia Newcastle Disease Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 212. Japan Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 213. South Korea Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 214. India Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Australia Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Taiwan Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 221. SAMEA Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 222. SAMEA Newcastle Disease Vaccine Sales Price by Type (2021-2026) & (USD/K Doses) Table 223. SAMEA Newcastle Disease Vaccine Sales Price by Type (2027-2032) & (USD/K Doses) Table 224. SAMEA Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 227. SAMEA Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 228. SAMEA Newcastle Disease Vaccine Sales Price by Application (2021-2026) & (USD/K Doses) Table 229. SAMEA Newcastle Disease Vaccine Sales Price by Application (2027-2032) & (USD/K Doses) Table 230. SAMEA Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Newcastle Disease Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Newcastle Disease Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 234. SAMEA Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 235. SAMEA Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 236. SAMEA Newcastle Disease Vaccine Sales Price by Country (2021-2026) & (USD/K Doses) Table 237. SAMEA Newcastle Disease Vaccine Sales Price by Country (2027-2032) & (USD/K Doses) Table 238. Brazil Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Argentina Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 240. Chile Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 241. Colombia Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 242. Peru Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 244. Israel Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 245. UAE Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 246. Turkey Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 247. Iran Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 248. Egypt Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Newcastle Disease Vaccine Distributors List Table 252. Newcastle Disease Vaccine Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Newcastle Disease Vaccine Image Figure 2. Global Newcastle Disease Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Newcastle Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccines Image Figure 5. Killed Vaccines Image Figure 6. Global Newcastle Disease Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Newcastle Disease Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Chicken Image Figure 9. Duck & Goose Image Figure 10. Other Image Figure 11. Global Newcastle Disease Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Newcastle Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Newcastle Disease Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Newcastle Disease Vaccine Sales (2021-2032) & (M Doses) Figure 17. Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 18. Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Newcastle Disease Vaccine Sales YoY (2021-2032) & (M Doses) Figure 20. Europe Newcastle Disease Vaccine Sales YoY (2021-2032) & (M Doses) Figure 21. China Newcastle Disease Vaccine Sales YoY (2021-2032) & (M Doses) Figure 22. Asia (Excluding China) Newcastle Disease Vaccine Sales YoY (2021-2032) & (M Doses) Figure 23. South America, Middle East and Africa Newcastle Disease Vaccine Sales YoY (2021-2032) & (M Doses) Figure 24. Global Newcastle Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Newcastle Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Newcastle Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Newcastle Disease Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Newcastle Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 31. Global Newcastle Disease Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Newcastle Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Newcastle Disease Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Newcastle Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 37. Global Newcastle Disease Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Newcastle Disease Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Newcastle Disease Vaccine Sales Share by Type (2021-2032) Figure 41. North America Newcastle Disease Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Newcastle Disease Vaccine Sales Share by Application (2021-2032) Figure 43. North America Newcastle Disease Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Newcastle Disease Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Newcastle Disease Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Newcastle Disease Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Newcastle Disease Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Newcastle Disease Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Newcastle Disease Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Newcastle Disease Vaccine Sales Share by Country (2021-2032) Figure 51. China Newcastle Disease Vaccine Revenue Share by Type (2021-2032) Figure 52. China Newcastle Disease Vaccine Sales Share by Type (2021-2032) Figure 53. China Newcastle Disease Vaccine Revenue Share by Application (2021-2032) Figure 54. China Newcastle Disease Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Newcastle Disease Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Newcastle Disease Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Newcastle Disease Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Newcastle Disease Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Newcastle Disease Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Newcastle Disease Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Newcastle Disease Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Newcastle Disease Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Newcastle Disease Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Newcastle Disease Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Newcastle Disease Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Newcastle Disease Vaccine Sales Share by Country (2021-2032) Figure 67. Newcastle Disease Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Newcastle Disease Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Chicken
  • Duck & Goose
  • Other
Companies covered
  • Merial
  • CEVA
  • QYH Biotech
  • Ringpu Biology
  • Yebio
  • Harbin Veterinary Research Institute
  • Merck Animal Health
  • DHN
  • Zoetis
  • ChengDu Tecbond
  • Elanco (Lohmann)
  • FATRO
  • CAVAC
  • Vaksindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Newcastle Disease Vaccine Market by Type
  3. 1.2.1 Global Newcastle Disease Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccines
  5. 1.2.3 Killed Vaccines
  6. 1.3 Newcastle Disease Vaccine Market by Application
  7. 1.3.1 Global Newcastle Disease Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Chicken
  9. 1.3.3 Duck & Goose
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Newcastle Disease Vaccine Market Dynamics
  1. 2.1 Newcastle Disease Vaccine Industry Trends
  2. 2.2 Newcastle Disease Vaccine Industry Drivers
  3. 2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Newcastle Disease Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Newcastle Disease Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Newcastle Disease Vaccine Revenue by Region
  3. 3.2.1 Global Newcastle Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Newcastle Disease Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Newcastle Disease Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Newcastle Disease Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Newcastle Disease Vaccine Sales by Region
  9. 3.4.1 Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Newcastle Disease Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Newcastle Disease Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Newcastle Disease Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Newcastle Disease Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Newcastle Disease Vaccine Sales by Manufacturers
  6. 4.2.1 Global Newcastle Disease Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Newcastle Disease Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Newcastle Disease Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Newcastle Disease Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Newcastle Disease Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier 3
5 Newcastle Disease Vaccine Market by Type
  1. 5.1 Global Newcastle Disease Vaccine Revenue by Type
  2. 5.1.1 Global Newcastle Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Newcastle Disease Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Newcastle Disease Vaccine Sales by Type
  6. 5.2.1 Global Newcastle Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Newcastle Disease Vaccine Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Newcastle Disease Vaccine Price by Type
6 Newcastle Disease Vaccine Market by Application
  1. 6.1 Global Newcastle Disease Vaccine Revenue by Application
  2. 6.1.1 Global Newcastle Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Newcastle Disease Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Newcastle Disease Vaccine Sales by Application
  6. 6.2.1 Global Newcastle Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Newcastle Disease Vaccine Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Newcastle Disease Vaccine Price by Application
7 Company Profiles
  1. 7.1 Merial
  2. 7.1.1 Merial Company Information
  3. 7.1.2 Merial Business Overview
  4. 7.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merial Newcastle Disease Vaccine Product Portfolio
  6. 7.1.5 Merial Recent Developments
  7. 7.2 CEVA
  8. 7.2.1 CEVA Company Information
  9. 7.2.2 CEVA Business Overview
  10. 7.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
  12. 7.2.5 CEVA Recent Developments
  13. 7.3 QYH Biotech
  14. 7.3.1 QYH Biotech Company Information
  15. 7.3.2 QYH Biotech Business Overview
  16. 7.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
  18. 7.3.5 QYH Biotech Recent Developments
  19. 7.4 Ringpu Biology
  20. 7.4.1 Ringpu Biology Company Information
  21. 7.4.2 Ringpu Biology Business Overview
  22. 7.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
  24. 7.4.5 Ringpu Biology Recent Developments
  25. 7.5 Yebio
  26. 7.5.1 Yebio Company Information
  27. 7.5.2 Yebio Business Overview
  28. 7.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
  30. 7.5.5 Yebio Recent Developments
  31. 7.6 Harbin Veterinary Research Institute
  32. 7.6.1 Harbin Veterinary Research Institute Company Information
  33. 7.6.2 Harbin Veterinary Research Institute Business Overview
  34. 7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
  36. 7.6.5 Harbin Veterinary Research Institute Recent Developments
  37. 7.7 Merck Animal Health
  38. 7.7.1 Merck Animal Health Company Information
  39. 7.7.2 Merck Animal Health Business Overview
  40. 7.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
  42. 7.7.5 Merck Animal Health Recent Developments
  43. 7.8 DHN
  44. 7.8.1 DHN Company Information
  45. 7.8.2 DHN Business Overview
  46. 7.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 DHN Newcastle Disease Vaccine Product Portfolio
  48. 7.8.5 DHN Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
  55. 7.10 ChengDu Tecbond
  56. 7.10.1 ChengDu Tecbond Company Information
  57. 7.10.2 ChengDu Tecbond Business Overview
  58. 7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
  60. 7.10.5 ChengDu Tecbond Recent Developments
  61. 7.11 Elanco (Lohmann)
  62. 7.11.1 Elanco (Lohmann) Company Information
  63. 7.11.2 Elanco (Lohmann) Business Overview
  64. 7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
  66. 7.11.5 Elanco (Lohmann) Recent Developments
  67. 7.12 FATRO
  68. 7.12.1 FATRO Company Information
  69. 7.12.2 FATRO Business Overview
  70. 7.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
  72. 7.12.5 FATRO Recent Developments
  73. 7.13 CAVAC
  74. 7.13.1 CAVAC Company Information
  75. 7.13.2 CAVAC Business Overview
  76. 7.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
  78. 7.13.5 CAVAC Recent Developments
  79. 7.14 Vaksindo
  80. 7.14.1 Vaksindo Company Information
  81. 7.14.2 Vaksindo Business Overview
  82. 7.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
  84. 7.14.5 Vaksindo Recent Developments
8 North America
  1. 8.1 North America Newcastle Disease Vaccine Market Size by Type
  2. 8.1.1 North America Newcastle Disease Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Newcastle Disease Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Newcastle Disease Vaccine Price by Type (2021-2032)
  5. 8.2 North America Newcastle Disease Vaccine Market Size by Application
  6. 8.2.1 North America Newcastle Disease Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Newcastle Disease Vaccine Price by Application (2021-2032)
  9. 8.3 North America Newcastle Disease Vaccine Market Size by Country
  10. 8.3.1 North America Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Newcastle Disease Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Newcastle Disease Vaccine Market Size by Type
  2. 9.1.1 Europe Newcastle Disease Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Newcastle Disease Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Newcastle Disease Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Newcastle Disease Vaccine Market Size by Application
  6. 9.2.1 Europe Newcastle Disease Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Newcastle Disease Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Newcastle Disease Vaccine Market Size by Country
  10. 9.3.1 Europe Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Newcastle Disease Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Newcastle Disease Vaccine Market Size by Type
  2. 10.1.1 China Newcastle Disease Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Newcastle Disease Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Newcastle Disease Vaccine Price by Type (2021-2032)
  5. 10.2 China Newcastle Disease Vaccine Market Size by Application
  6. 10.2.1 China Newcastle Disease Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Newcastle Disease Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Newcastle Disease Vaccine Market Size by Type
  2. 11.1.1 Asia Newcastle Disease Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Newcastle Disease Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Newcastle Disease Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Newcastle Disease Vaccine Market Size by Application
  6. 11.2.1 Asia Newcastle Disease Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Newcastle Disease Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Newcastle Disease Vaccine Market Size by Country
  10. 11.3.1 Asia Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Newcastle Disease Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Newcastle Disease Vaccine Market Size by Type
  2. 12.1.1 SAMEA Newcastle Disease Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Newcastle Disease Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Newcastle Disease Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Newcastle Disease Vaccine Market Size by Application
  6. 12.2.1 SAMEA Newcastle Disease Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Newcastle Disease Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Newcastle Disease Vaccine Market Size by Country
  10. 12.3.1 SAMEA Newcastle Disease Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Newcastle Disease Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Newcastle Disease Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Newcastle Disease Vaccine Value Chain Analysis
  2. 13.1.1 Newcastle Disease Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Newcastle Disease Vaccine Production Mode & Process
  6. 13.2 Newcastle Disease Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Newcastle Disease Vaccine Distributors
  9. 13.2.3 Newcastle Disease Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst